Mary Ann Liebert: Delivering Large Genes to the Retina Is Problematic
November 12, 2019
November 12, 2019
NEW ROCHELLE, New York, Nov. 12 -- Mary Ann Liebert Inc. issued the following news release:
A new study has shown that a commonly used vector for large gene transfer can successfully deliver genes to retinal cells in the laboratory, but when injected subretinally into rats it provokes a robust and acute inflammatory response. A detailed description of this study and the implications of its results are published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, In . . .
A new study has shown that a commonly used vector for large gene transfer can successfully deliver genes to retinal cells in the laboratory, but when injected subretinally into rats it provokes a robust and acute inflammatory response. A detailed description of this study and the implications of its results are published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, In . . .